Drugs / PPV-23 Vaccine
last change Aug 2014 re-read 2 minutes ago

PPV-23 Vaccine

Vaccine

Developed for
pneumococcal infection
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID)

Trials 1 · a red edge is where a trial was stopped

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01443117 ? → Aug 2014 HIV infectious disease, pneumococcal infection National Institute of Allergy and Infectious Diseases (NIAID) Withdrawn No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PPV-23 Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01443117
Modality Vaccine “PPV-23 vaccineNCT01443117
Route Intramuscular “Administered as a 0.5 mL IM dose” NCT01443117